Publications by authors named "Heike Weidner"

Claim this Profile
A
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma.
Michael Rade, David Fandrei, Markus Kreuz, Sabine Seiffert, Anja Grahnert, Heike Weidner

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Implications of Splenomegaly in BCMA-Directed CAR T-Cell Therapy for Relapsed Myeloma.
Thomas C Wiemers, Maximilian Ferle, Jonas Ader, Veronika Sotikova, David Fandrei, Heike Weidner

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.
Patrick Born, David Fandrei, Song Yau Wang, Carmen Perez-Fernandez, Luise Fischer, Heike Weidner

Hemasphere· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma.
David Fandrei, Sabine Seiffert, Michael Rade, Susanne Rieprecht, Nico Gagelmann, Heike Weidner

Blood Cancer Discov· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow transplantation reduces FGF-23 levels and restores bone formation in myelodysplastic neoplasms.
Heike Weidner, Ulrike Baschant, Maria G Ledesma-Colunga, Karolina Basiak, Elena Tsourdi

Leukemia· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Heike Weidner

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule CBP/p300 histone acetyltransferase inhibition mobilizes leukocytes from the bone marrow via the endocrine stress response.
Nikolai P Jaschke, Dorit Breining, Maura Hofmann, Sophie Pählig, Ulrike Baschant, Heike Weidner

Immunity· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferrin receptor 2 deficiency promotes macrophage polarization and inflammatory arthritis.
Maria G Ledesma-Colunga, Ulrike Baschant, Heike Weidner, Tiago C Alves, Peter Mirtschink

Redox Biol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteoprogenitor SFRP1 prevents exhaustion of hematopoietic stem cells via PP2A-PR72/130-mediated regulation of p300.
Franziska Hettler, Christina Schreck, Sandra Romero Marquez, Thomas Engleitner, Baiba Vilne, Heike Weidner

Haematologica· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compartment-specific mutational landscape of clonal hematopoiesis.
Luise Hartmann, Judith S Hecker, Maja Rothenberg-Thurley, Jennifer Rivière, Madlen Jentzsch, Heike Weidner

Leukemia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept mitigates bone loss driven by myelodysplastic neoplasms and estrogen-deficiency in mice.
Heike Weidner, Manja Wobus, Lorenz C Hofbauer, Martina Rauner, Uwe Platzbecker

Leukemia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.
Maik Herbig, Angela Jacobi, Manja Wobus, Heike Weidner, Anna Mies

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells.
Manja Wobus, Anna Mies, Nandini Asokan, Uta Oelschlägel, Kristin Möbus, Heike Weidner

Leukemia· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shaping the bone through iron and iron-related proteins.
Maria G Ledesma-Colunga, Heike Weidner, Maja Vujic Spasic, Lorenz C Hofbauer, Ulrike Baschant

Semin Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interactions of Anemia, FGF-23, and Bone in Healthy Adults-Results From the Study of Health in Pomerania (SHIP).
Anke Hannemann, Matthias Nauck, Henry Völzke, Heike Weidner, Uwe Platzbecker

J Clin Endocrinol Metab· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disruption of BMP Signaling Prevents Hyperthyroidism-Induced Bone Loss in Male Mice.
Franziska Lademann, Heike Weidner, Elena Tsourdi, Ravi Kumar, Eddy Rijntjes

J Bone Miner Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes.
Heike Weidner, Ulrike Baschant, Franziska Lademann, Maria G Ledesma Colunga, Ekaterina Balaian

JCI Insight· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes.
Ekaterina Balaian, Heike Weidner, Manja Wobus, Ulrike Baschant, Angela Jacobi

Ann Hematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans.
Sylvia Thiele, Anke Hannemann, Maria Winzer, Ulrike Baschant, Heike Weidner

Endocr Connect· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling.
Martina Rauner, Ulrike Baschant, Antonella Roetto, Rosa Maria Pellegrino, Sandra Rother, Heike Weidner

Nat Metab· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling.
Martina Rauner, Ulrike Baschant, Antonella Roetto, Rosa Maria Pellegrino, Sandra Rother, Heike Weidner

Nat Metab· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway.
Ekaterina Balaian, Manja Wobus, Heike Weidner, Ulrike Baschant, Maik Stiehler

Haematologica· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors.
Ulrike Baschant, Martina Rauner, Ekaterina Balaian, Heike Weidner, Antonella Roetto

Haematologica· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis